Headlines

Deep Dive Into Abbott Laboratories Stock: Analyst Perspectives (6 Ratings)

Latest Ratings for ABT

Date Firm Action From To
Jan 2022 Morgan Stanley Maintains Overweight
Jan 2022 Raymond James Maintains Outperform
Jan 2022 Morgan Stanley Maintains Overweight

View More Analyst Ratings for ABT

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *